Lv1
40 积分 2024-11-27 加入
Envafolimab: First Approval
8天前
已完结
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors
8天前
已完结
Metabolomics of asthma, COPD, and asthma-COPD overlap: an overview
15天前
已完结
[Annual research progress in chronic obstructive pulmonary disease 2024]
2个月前
已完结
Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models
2个月前
已关闭
Intranasal transmucosal drug delivery: An alternative approach to the parenteral route for medical emergencies
2个月前
已完结
Current Industry Best Practice on in-use Stability and Compatibility Studies for Biological Products
2个月前
已完结
Inflammatory cell profiles and T‐lymphocyte subsets in chronic obstructive pulmonary disease and severe persistent asthma
2个月前
已完结
Translate Pharmacokinetics of PD-1/PD-L1 Monoclonal Antibodies from Cynomolgus Monkey to Human: Comparison of Different Approaches
3个月前
已完结
Comparison of Airway Remodeling in Two Different Endotypes of Allergic Asthma
4个月前
已完结
皖公网安备34019202002308
